Michele B.
- Country
- Italy
- Department
- Dipartimento di Oncologia Clinica
Research Overview
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- Phase 2 Study of ACR-368 and Gemcitabine in Subjects with Endometrial Cancer
- Phase 3 Randomized Open‑Label Study of INCB123667 Versus Investigator’s Choice Chemotherapy Combination in Platinum‑Resistant Ovarian Cancer with Cyclin E1 Overexpression
Data & Insights
Has run more than one trial at 211 of 380 partner sites.
Specializations
Gynecologic Oncology
Specializes in investigating novel therapeutic approaches for high-grade serous ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. Focuses on treatment strategies for both platinum-resistant and recurrent disease states.
- Advanced Ovarian Cancer Management
- Platinum-Resistant Disease Treatment
- Peritoneal Cancer Therapeutics
Endometrial Cancer Research
Conducts studies on advanced and recurrent endometrial cancer, with particular emphasis on maintenance therapies and innovative treatment combinations including immunotherapy approaches.
- MMR-Deficient Endometrial Cancer
- Post-Platinum Treatment Strategies
- Chemotherapy-Immunotherapy Combinations
Innovative Therapeutics
Evaluates emerging therapeutic agents including targeted therapies and immunotherapy combinations. Investigates maintenance treatment strategies and novel drug combinations for gynecologic cancers.
- Targeted Molecular Therapies
- Combination Treatment Approaches
- Maintenance Therapy Optimization
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.